ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunosuppression"

  • 2015 American Transplant Congress

    Reduced Intensity Immunosuppression Protocol Lowers Drug Costs and May Decrease Incidences of BK Viremia and Readmissions After Kidney and Kidney/Pancreas Transplant

    M. Mariski,1 A. DeGolovine,2 W. Dar,2 J. Bynon,2 H. Adrogué,2 M. Hobeika.2

    1Dept of Pharmacy, Memorial Hermann Texas Medical Center, Houston, TX; 2Division of Immunology and Organ Transplantation, University of Texas, Houston, TX.

    Purpose: To evaluate the effects of a reduced intensity immunosuppression protocol on drug costs and rates of BK viremia and readmissions.Methods: In response to high…
  • 2015 American Transplant Congress

    Long-Term Results After Heart Transplantation – A Randomized Trial Comparing Tacrolimus Versus Cyclosporine A in Combination With Mycophenolate Mofetil After a Mean Duration of 15 Years

    S. Guethoff,1 C. Grinninger,1 B. Reichart,2 P. Ueberfuhr,1 C. Hagl,1 B. Meiser.2

    1Department of Cardiac Surgery, Ludwig-Maximilians University, Munich, Germany; 2Transplantation Center, Ludwig-Maximilians University, Munich, Germany.

    Purpose. Development of cardiac allograft vasculopathy (CAV), renal dysfunction and malignancies are the main risks due to long-term immunosuppressive therapy after heart transplantation (HTx). We…
  • 2015 American Transplant Congress

    Short- and Long-Term Outcomes of Mycophenolate Versus Azathioprine in a Large Cohort of Renal Transplant Recipients

    L. Bowman,1 T. Horwedel,1 J. Hagopian,1 D. Brennan.2

    1Barnes-Jewish Hospital, St. Louis; 2Washington University School of Medicine, St. Louis.

    Purpose: Early studies comparing mycophenolate mofetil (MMF) to azathioprine (AZA) post-renal transplantation demonstrated superiority of MMF over AZA for the prevention of acute rejection (AR).…
  • 2015 American Transplant Congress

    CFZ533: Assessment of Immunomodulatory Activity Following Single Doses of a Novel Anti-CD40 mAb in Healthy Volunteers

    A. Slade,1 J. Doucet,2 P. Koo,1 P. Espie,2 J. Rush,2 C. Tomek,3 J. Klupp.2

    1Novartis Institute for Biomedical Research, East Hanover, NJ; 2Novartis Institute for Biomedical Research, Basel, Switzerland; 3Celerion, Inc, Lincoln, NE.

    Blocking the CD40-CD154 pathway has been shown to effectively prolong renal allograft survival in non-human primates. CFZ533 is a novel, fully human, Fc-silent, anti-CD40 monoclonal…
  • 2015 American Transplant Congress

    Adherence Time-Profiles of Renal Transplant Patients During the Three First Years Post-Transplantation

    C. Villeneuve,1,2,3 C. Monchaud,1,2,3 M. Essig,2,4 M.-L. Laroche,1,3 A. Coubret,1 I. Lacroix,5 S. Bouchet,6,7,8 D. Fruit,1,2,3 P. Merville,9 N. Kamar,10,11,12 P. Marquet,1,2,3 A. Rousseau.2,13

    1Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France; 2UMR-850, INSERM, Limoges, France; 3Laboratory of Pharmacology, Univ Limoges, Limoges, France; 4Nephrology, Dialysis and Transplantation, CHU Limoges, Limoges, France; 5Laboratory of Clinical Pharmacology, CHU Toulouse, Toulouse, France; 6UMR-876, INSERM, Bordeaux, France; 7Clinical Pharmacology, Toxicology, CHU Bordeaux, CHU Bordeaux, France; 8University Victor Ségalen Bordeaux 2, Bordeaux, France; 9Department of Nephrology, CHU Bordeaux, CHU Bordeaux, France; 10Department of Nephrology and Organ Transplantation, CHU Toulouse, Toulouse, France; 11Univ Toulouse, Toulouse, France; 12UMR-1043, IFR-BMT, INSERM, Toulouse, France; 13Biophysics, Faculty of Pharmacy, Limoges, France.

    Non-adherence to immunosuppressants (IS) has been reported to increase morbidity and mortality of transplant patients.Our objective was to investigate adherence to IS in renal transplant…
  • 2015 American Transplant Congress

    Forty-Seven Consecutive Simultaneous Liver-Kidney Transplants With Steroid Free Immunosuppression After Rabbit Antithymocyte Globulin Induction

    D. Hall, V. Puri, S. Mabry, J. Vanatta, J. Eason.

    Transplantation, University of Tennessee/Methodist University Hospital Transplant Institute, Memphis, TN.

    Introduction: Utilization of rabbit antithymocyte globulin (RATG) induction as part of a steroid free immunosuppression protocol in orthotopic liver transplantation has gained wide acceptance in…
  • 2015 American Transplant Congress

    DNA Methytransferase 1 Inhibition Potently Suppresses T Cell Cycle Progression Through Demethylation of the Key Cell Cycle Inhibitors p15, p16, p21 and p27

    T. Ma, Y. Pei, R. Tao.

    Department of Hepatobiliary-Pancreatic Surgery, Zhejiang Provincial Peoples' Hospital, Hangzhou, Zhejiang Province, China.

    Background: Epigenetic mechanisms like acetylation and methylation have been gradually appreciated to play a critical role in the generation and function of various immune cells.…
  • 2015 American Transplant Congress

    Living and Dead Mesenchymal Stem Cells Induce an Immunosuppressive Response in an Experimental Sepsis Model

    F. Luk,1 M. Roemeling-van Rhijn,1 S. de Witte,1 S. Korevaar,1 R. de Bruin,2 M. Betjes,1 C. Baan,1 M. Hoogduijn.1

    1Nephrology and Transplantation, Dept. of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands; 2Transplant Surgery, Dept. of Surgery, Erasmus Medical Center, Rotterdam, Netherlands.

    There is evolving interest in the use of mesenchymal stem cells (MSC) as a cell therapeutic agent after solid organ transplantation. The nature of the…
  • 2015 American Transplant Congress

    Induction Avoidance in 2-Haplotype-Matched White Living Kidney Transplantation

    Z. Brifkani,1 T. Alhamad,1 T. Horwedel,2 R. Delos Santos,1 T. Maw,1 D. Brennan.1

    1Transplant Nephrology, Washington University in St. Louis, St. Louis, MO; 2Barnes Jewish Hospital, St. Louis, MO.

    Background: We hypothesize that 2-haplotype matched white living kidney transplant recipients carry a low immunologic risk for rejection, and therefore do not give induction therapy…
  • 2015 American Transplant Congress

    Medication Non-Adherence in Those Waiting for a Transplant

    M. Wakefield,1 D. Murillo,2 C. Russell,3 C. Ashbaugh,1 S. Potts,2 L. Blakley,2 A. Deere.1

    1Department of Surgery, University of Missouri, Columbia, MO; 2Transplant Institute, Research Hospital, Kansas City, MO; 3School of Nursing and Health Studies, University of Missouri-Kansas City, Kansas City, MO.

    Purpose: Though poor medication adherence among adult kidney transplant patients is alarmingly high with distressing consequences, no one has systematically examined medication non-adherence in those…
  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 138
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences